Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:

Find A Business
or Browse Listings

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

12.86 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

20 21 Next >

A Look Into Healthcare Sector Value Stocks ↗

December 25, 2023

Via Benzinga

These 3 Dividend Stocks Are Undervalued Using This Key Valuation Metric ↗

November 30, 2023

Book value is a valuable metric for discovering undervalued stocks. These 3 dividend payers are trading below book value.

Via Talk Markets

Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024 ↗

November 30, 2023

Often the best investments are out-of-favor and trade at silly cheap valuations. Check out three such growth stocks with huge upside.

Via InvestorPlace

7 Low P/E Stocks Poised to Rebound ↗

November 20, 2023

Each of these seven low P/E value stocks trades for under 10 times earnings, but could rise to a much higher valuation as sentiment improves.

Via InvestorPlace

Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal ↗

November 18, 2023

Legend Biotech partnered its DLL3 CAR-T candidates to Novartis in a $1.2 billion agreement, with $100 million offered upfront. Novartis will own worldwide rights to develop, manufacture, and...

Via Talk Markets

Recap: Viatris Q3 Earnings ↗

November 07, 2023

Via Benzinga

2 Top Value Stocks to Buy in October ↗

October 08, 2023

These two blue chip stocks offer top-notch yields, attractive valuations, and solid long-term prospects.

Via The Motley Fool

Viatris Stock: Bear vs. Bull ↗

August 31, 2023

This is a case where both sides have compelling arguments.

Via The Motley Fool

5 Value Stocks To Watch In The Healthcare Sector ↗

November 13, 2023

Via Benzinga

3 Large-Cap Stocks to Buy Trading Below Book Value ↗

November 07, 2023

There aren’t too many large-cap stocks in the S&P 500 trading below book value. But here are three possibilities.

Via InvestorPlace

Topics Stocks

Ozempic Just Shrugged Off a Challenge From Viatris. What Does This Mean for Investors? ↗

October 31, 2023

Viatris now faces a narrower path to commercializing a generic copy of Ozempic.

Via The Motley Fool

Viatris Just Sold Off 3 Key Segments. Is It Still a Buy? ↗

October 13, 2023

There's a chance shareholders won't notice any difference.

Via The Motley Fool

2 Healthcare Dividend Stocks You'd Regret Not Buying on the Dip ↗

October 08, 2023

These stocks may not be for everyone, but income-seekers might find what they're looking for in them.

Via The Motley Fool

Obesity Drug Wegovy's Triumph to Catapult Novo Holdings In Golden Era Of Wealth Boost ↗

October 03, 2023

Novo Holdings, the controlling shareholder of Novo Nordisk A/S (NYSE: NVO), is bracing for a significant influx of capital stemming from the thriving success of the weight-loss drug Wegovy.

Via Benzinga

Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris ↗

August 24, 2023

Via The Motley Fool

Where Will Viatris Be in 5 Years? ↗

August 18, 2023

Can this become a good growth business to invest in?

Via The Motley Fool

Earnings Scheduled For November 7, 2023 ↗

November 07, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Via Benzinga

'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories ↗

October 03, 2023

Benzinga

Via Benzinga

Novo Nordisk Weight Loss Drug Patent Battle Against Viatris - Emerges As Winner ↗

October 03, 2023

Novo Nordisk A/S (NYSE: NVO) successfully defended two pivotal patent claims linked to the main ingredient in its popular weight-loss and diabetes drugs,

Via Benzinga

Topics Intellectual Property

Viatris Stock Bounds Higher As Divestitures Reach Nearly $7 Billion ↗

October 02, 2023

The company is retaining the rights to specific over-the-counter drugs in some markets.

Via Investor's Business Daily

Viatris Phase 1 Asset Divestiture Story: Plans To Sell Certain OTC Products, Women's Healthcare Business & More ↗

October 02, 2023

Viatris Inc (NASDAQ: VTRS) disclosed multiple deals to sell remaining assets to conclude Phase 1 of planned asset disposition by

Via Benzinga

Could Viatris Stock Help You Become a Millionaire? ↗

September 30, 2023

Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?

Via The Motley Fool

Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields ↗

September 27, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report ↗

September 26, 2023

Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to...

Via Benzinga

NASDAQ: VTRS Shareholder Notice Investigation over Potential Wrongdoing by Certain Directors of Viatris Inc. ↗

September 22, 2023

San Diego, CA -- (SBWIRE) -- 09/22/2023 -- Certain directors of Viatris Inc.are under investigation concerning potential breaches of fiduciary duties.

Via SBWire

'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase ↗

September 22, 2023

The analyst illustrated how the dominant force in stock market returns for 2023 has been the "Magnificent 7."

Via Benzinga

Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks ↗

September 14, 2023

These stocks offer some mouth-watering payouts.

Via The Motley Fool

3 Pharmaceutical Stocks That Are Too Cheap to Ignore ↗

September 09, 2023

Viatris, GSK, and Organon are all trading at less than 7 times earnings.

Via The Motley Fool

CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know ↗

September 01, 2023

CVS just fired a shot across Viatris' bow.

Via The Motley Fool

VIATRIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Viatris Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 22, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Viatris Inc. - Common Stock (NQ:VTRS)

All News about Viatris Inc. - Common Stock